Resources

£215 million additional investment for UK innovation centres

The UK Government has announced a £55m five-year investment in Medicines Discovery Catapult.

Overcoming bottlenecks in early drug discovery with the power of sound

Medicines Discovery Catapult and AstraZeneca collaborate to unlock the potential of Acoustic Mist Ionisation Mass Spectrometry.

Building an ecosystem to support data-driven health startups

Accelerating progress and increasing success rates

Barriers to the release of human tissue for clinical trials research in the UK: a national survey of cellular pathology laboratories on behalf of the National Cancer Research Institute’s Cellular Molecular Pathology (CM-Path) initiative

Novel deep learning drug discovery platform gets £1 million innovation boost

OptibriumTM, Intellegens and Medicines Discovery Catapult awarded funding to apply machine learning in drug discovery.

Writing a winning grant application

5 key things to consider before you apply

Bubbling up: Introducing a new drug delivery method, microbubbles

Chapter One – Atlas of the Radical SAM Superfamily: Divergent Evolution of Function Using a “Plug and Play” Domain

Dr Martin Main appointed to SLAS Discovery Editorial Board

Our Head of Molecular Technologies, Dr Martin Main, has been invited to serve as a member of the SLAS Discovery Editorial Board.